Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Cerilliant
QuintilesIMS
Johnson and Johnson
AstraZeneca
Chubb
UBS
Merck

Generated: September 20, 2018

DrugPatentWatch Database Preview

Actavis Labs Fl Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has seventy-one approved drugs.

There are two tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Actavis Labs Fl Inc
US Patents:0
Tradenames:56
Ingredients:54
NDAs:71

Drugs and US Patents for Actavis Labs Fl Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc NITROGLYCERIN nitroglycerin TABLET;SUBLINGUAL 203693-003 Oct 16, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 075604-002 Apr 10, 2002 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 206470-002 Jun 2, 2016 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc HYDROCODONE BITARTRATE AND IBUPROFEN hydrocodone bitartrate; ibuprofen TABLET;ORAL 077454-001 Jun 23, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076267-003 Feb 11, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 076996-002 Apr 19, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Teva
Fuji
UBS
Colorcon
Cantor Fitzgerald
Deloitte
Johnson and Johnson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.